Access cutting-edge equine encephalitis treatment through this clinical trial at a research site in Lenexa. Study-provided care at no cost to qualified participants.
Access equine encephalitis specialists in Lenexa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related equine encephalitis treatment provided free
This phase 2 clinical trial will investigate an optimal dose, dosing regimen, and evaluate reactogenicity, safety and immunogenicity in healthy adult participants of the recombinant, multivalent MVA-BN-WEV vaccine. MVA-BN-WEV is intended for active immunization for prevention of disease induced by VEEV and EEEV, in persons aged 18 years and older at high risk of exposure.
Sponsor: Bavarian Nordic
Check if you qualify for this equine encephalitis clinical trial in Lenexa, KS
If you're searching for equine encephalitis treatment options in Lenexa, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lenexa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced equine encephalitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.